Jingle Bell JogZippity Doo Dah gives to BCHJackson Free ClinicCommencement 2014
  • Division of Hematology & Oncology

    The Division of Hematology and Oncology focuses on patients with malignant diseases and/or with disorders of the blood and blood-forming organs. The activities of the division fall into three categories: clinical research, teaching, and patient care.

    In regard to clinical research, the division is active in two major cooperative cancer clinical trials groups sponsored by the National Cancer Institute: NRG Oncology and the Southwest Oncology Group. In addition, the division has a broad menu of investigator-initiated and industry-sponsored clinical studies. Active trials span the entire spectrum of malignant diseases and benign hematology and number more than 50 active studies at any one time. The division also holds a leadership role in NRG Oncology. The division also collaborates with the translational scientists in the UMMC Cancer Institute in a variety projects that seek to translate findings in the laboratory to active use in the clinic to benefit patients with cancer.

    In regard to teaching, the division has an active training program for fellows in hematology and oncology. Currently this program has 8 fellows in training. The division also oversees active teaching efforts for medical students, for residents in internal medicine, and for practicing physicians.

    In regard to patient care, the division has two sections, an Oncology Section and a Hematology Section.

    The Oncology Section focuses on patients with solid tumors (cancers other than hematologic malignancies). Section faculty participate actively in programs of the UMMC Cancer Institute including programs focusing on: breast cancer, lung cancer, head and neck cancer, gastrointestinal cancer, genitourinary cancer, gynecologic cancer, melanoma and other skin cancers, sarcomas, and neuro-oncologic tumors.

    The Hematology Section focuses on patients with diseases of the blood and blood-forming organs. These include in particular leukemia, lymphoma, multiple myeloma, and sickle cell anemia along with other benign hematologic disorders. The section also staffs a 12-bed bone marrow transplant unit which is certified by the Foundation for the Accreditation of Cellular Therapy.